| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/LT.20418 |
| P698 | PubMed publication ID | 15973710 |
| P50 | author | Francois Durand | Q55187615 |
| Thomas Decaens | Q62096202 | ||
| P2093 | author name string | Christophe Duvoux | |
| Sebastien Dharancy | |||
| Yvon Calmus | |||
| Françoise Roudot-Thoraval | |||
| Carole Meyer | |||
| Olivier Boillot | |||
| Daniel Cherqui | |||
| Jean Hardwigsen | |||
| Jean Gugenheim | |||
| Solange Bresson-Hadni | |||
| Karim Boudjema | |||
| Daniel Dhumeaux | |||
| Olivier Chazouilleres | |||
| Pierre-Henri Bernard | |||
| Christian Ducerf | |||
| Georges Philippe Pageaux | |||
| P433 | issue | 7 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 767-775 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma | |
| P478 | volume | 11 |
| Q28392783 | 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma |
| Q28394414 | 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma |
| Q64272871 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q91599660 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q42055473 | A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads. |
| Q36903588 | A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation. |
| Q46043164 | Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantation |
| Q89927855 | Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma |
| Q46419370 | Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation |
| Q89953523 | Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation |
| Q26852105 | Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation |
| Q39141900 | Bridging locoregional therapy: Longitudinal trends and outcomes in patients with hepatocellular carcinoma |
| Q89641626 | Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same? |
| Q88046517 | Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere? |
| Q47136271 | Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation |
| Q34065055 | Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list. |
| Q35168279 | Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. |
| Q40014368 | Current status of therapy for hepatocellular carcinoma |
| Q43262772 | Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma? |
| Q37162432 | Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. |
| Q57225691 | Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria |
| Q56985915 | Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas |
| Q34562491 | Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC. |
| Q38976824 | HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations? |
| Q26781798 | Hepatocellular Carcinoma and Liver Transplantation: State of the Art |
| Q35162986 | Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation |
| Q37002552 | Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival |
| Q37609440 | Independent prognostic factors for posttransplant survival in hepatocellular carcinoma patients undergoing liver transplantation |
| Q37054978 | Liver embolizations in oncology: a review. Part I. Arterial (chemo)embolizations |
| Q88757282 | Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies |
| Q38635611 | Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival |
| Q64980905 | Liver transplantation for hepatocellular carcinoma: Where do we stand? |
| Q37625446 | Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. |
| Q36955647 | Management of hepatocellular carcinoma: Enlightening the gray zones. |
| Q26998606 | Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience |
| Q47100371 | Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation |
| Q33594862 | Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand? |
| Q51747220 | Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma |
| Q33788043 | Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation. |
| Q35221816 | Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis |
| Q26772329 | Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation |
| Q37623171 | Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma |
| Q39210533 | Preoperative portal venous and hepatic arterial embolization of tumor |
| Q38070128 | Prevention of recurrence after curative treatment for hepatocellular carcinoma |
| Q33387430 | Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ |
| Q36357310 | Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance |
| Q34303040 | Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. |
| Q26851627 | Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma |
| Q36561656 | Role of surgical resection for multiple hepatocellular carcinomas |
| Q46843872 | Sensitive serum parameters for hepatocellular carcinoma recurrence monitoring after liver transplantation: a case report |
| Q36863488 | Strategies for the management of hepatocellular carcinoma |
| Q27005375 | Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation |
| Q81795140 | Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? |
| Q37625811 | The management of patients awaiting liver transplantation |
| Q79959752 | Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma |
| Q26784223 | Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system |
| Q35207822 | Transcatheter arterial chemoembolization of hepatocellular carcinoma as a bridge to liver transplantation: a retrospective study |
| Q79460894 | [Liver resection and transplantation for hepatic tumors] |
Search more.